AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 57 filers reported holding AUDENTES THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $3,640,000 | +139.6% | 93,275 | +30.9% | 0.00% | +200.0% |
| Q4 2018 | $1,519,000 | -71.7% | 71,249 | -47.4% | 0.00% | -50.0% |
| Q3 2018 | $5,366,000 | +92.1% | 135,558 | +85.5% | 0.00% | 0.0% |
| Q2 2018 | $2,793,000 | +97.9% | 73,093 | +55.6% | 0.00% | +100.0% |
| Q1 2018 | $1,411,000 | -18.6% | 46,970 | -15.3% | 0.00% | 0.0% |
| Q4 2017 | $1,733,000 | +6.4% | 55,471 | -4.5% | 0.00% | 0.0% |
| Q3 2017 | $1,628,000 | +31.9% | 58,107 | -9.9% | 0.00% | 0.0% |
| Q2 2017 | $1,234,000 | +526.4% | 64,497 | +459.3% | 0.00% | – |
| Q1 2017 | $197,000 | -9.2% | 11,532 | -2.8% | 0.00% | – |
| Q4 2016 | $217,000 | – | 11,866 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 1,204,615 | $37,644,219,000 | 39.61% |
| Casdin Capital, LLC | 400,000 | $12,500,000 | 3.04% |
| Opaleye Management Inc. | 210,000 | $6,652,000 | 2.13% |
| Orbimed Advisors | 4,129,638 | $129,051,000 | 1.63% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,190,516 | $37,204,000 | 1.46% |
| Redmile Group, LLC | 929,326 | $29,041,000 | 1.26% |
| Cormorant Asset Management, LP | 337,876 | $10,559,000 | 1.10% |
| Perceptive Advisors | 781,309 | $24,416,000 | 0.81% |
| Rock Springs Capital Management LP | 525,000 | $16,406,000 | 0.74% |
| Virtus ETF Advisers LLC | 11,898 | $372,000 | 0.47% |